Literature DB >> 22508338

Relation of chemokines to BMI and insulin resistance at ages 18-21.

S Ognjanovic1, D R Jacobs, J Steinberger, A Moran, A R Sinaiko.   

Abstract

OBJECTIVE: In obesity, adipose tissue becomes a significant source of chemokines and inflammatory cytokines that are associated with chronic systemic low-grade inflammation and may lead to insulin resistance. Studies in children have mainly focused on inflammatory cytokines and there are limited data for chemokines in adolescents and young adults. We studied the relation of chemokines to cardiovascular (CV)-risk factors, insulin resistance and adipocytokines in 18-21-year-old individuals. SUBJECTS AND
DESIGN: Cross-sectional data collected in a cohort originally enrolled at mean age 13, with data for the present study obtained from 252 examined at age 18.7±0.1 years.
METHODS: Multiple linear regression models were used to analyze the associations among chemokines (monocyte chemotactic protein-1, macrophage inflammatory protein-1β (MIP-1β), visfatin and interleukin-8 (IL-8)) and between chemokines and body mass index (BMI), glucose, lipids, blood pressure (BP), insulin resistance (euglycemic hyperinsulinemic clamp) and adipocytokines (IL-6, TNF-α and adiponectin).
RESULTS: Chemokine levels were significantly intercorrelated. Significant associations (P<0.05) with adjustment for age, race and sex included: MIP-1β with waist circumference and IL-6, IL-8 with systolic BP and visfatin with IL-6. No other significant relations were found between the chemokines and the other variables. Further adjustment for BMI did not alter these conclusions.
CONCLUSION: Considered in the context of prior studies in children and adults, these results suggest that in large part, the association between chemokines and CV risk or inflammatory factors does not appear to develop until adult life.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22508338     DOI: 10.1038/ijo.2012.61

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  6 in total

1.  Dynamic and extensive metabolic state-dependent regulation of cytokine expression and circulating levels.

Authors:  Pia S Petersen; Xia Lei; Marcus M Seldin; Susana Rodriguez; Mardi S Byerly; Andrew Wolfe; Scott Whitlock; G William Wong
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-10-15       Impact factor: 3.619

2.  LPS response pattern of inflammatory adipokines in an in vitro 3T3-L1 murine adipocyte model.

Authors:  Salvatore Chirumbolo; Guido Franceschetti; Elena Zoico; Clara Bambace; Luciano Cominacini; Mauro Zamboni
Journal:  Inflamm Res       Date:  2014-02-14       Impact factor: 4.575

3.  Is serum zinc associated with pancreatic beta cell function and insulin sensitivity in pre-diabetic and normal individuals? Findings from the Hunter Community Study.

Authors:  Khanrin P Vashum; Mark McEvoy; Abul Hasnat Milton; Md Rafiqul Islam; Stephen Hancock; John Attia
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

4.  Beneficial Effects of Pterocarpan-High Soybean Leaf Extract on Metabolic Syndrome in Overweight and Obese Korean Subjects: Randomized Controlled Trial.

Authors:  Ri Ryu; Tae-Sook Jeong; Ye Jin Kim; Ji-Young Choi; Su-Jung Cho; Eun-Young Kwon; Un Ju Jung; Hyeon-Seon Ji; Dong-Ha Shin; Myung-Sook Choi
Journal:  Nutrients       Date:  2016-11-18       Impact factor: 5.717

5.  Is serum zinc level associated with prediabetes and diabetes?: a cross-sectional study from Bangladesh.

Authors:  Md Rafiqul Islam; Iqbal Arslan; John Attia; Mark McEvoy; Patrick McElduff; Ariful Basher; Waliur Rahman; Roseanne Peel; Ayesha Akhter; Shahnaz Akter; Khanrin P Vashum; Abul Hasnat Milton
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

6.  Multiplex cytokine concentration measurement: how much do the medium and handling matter?

Authors:  Luke Parkitny; James H McAuley; Patrick J Kelly; Flavia Di Pietro; Barbara Cameron; G Lorimer Moseley
Journal:  Mediators Inflamm       Date:  2013-09-28       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.